Literature DB >> 16305334

Stable plasmid-based siRNA silencing of gene expression in human embryonic stem cells.

Yi-Ping Liu1, Svetlana V Dambaeva, Oksana V Dovzhenko, Mark A Garthwaite, Thaddeus G Golos.   

Abstract

RNA interference (RNAi) using short inhibitory RNAs (siRNAs) has been widely explored for the suppression of cellular mRNA levels to investigate the function of specific genes, including gene function in differentiation and development. The establishment of human embryonic stem cell (hESC) models for differentiation of selected lineages is an area of intense interest and activity. On the basis of our previous work with stable overexpression of enhanced green fluorescent protein (EGFP) in hESC, we used plasmid vector-based siRNA expression to silence EGFP expression in stably-transfected hESC. After hygromycin selection, we derived several cell lines in which EGFP expression was significantly reduced. At the genomic DNA level, there was no difference between the two cell lines and the parental H1EGFP cell line when analyzed with quantitative PCR; however, there were significant differences among the three cell lines at the RNA and protein levels as analyzed with real-time RT-PCR and Western blotting. From these data, we conclude that the decrease in EGFP expression was caused by RNAi, not by genomic DNA loss. Down-regulation of EGFP expression was sustained through multiple passages of both siEGFP cell lines. This simple silencing system will allow novel investigations of target gene function in hESC self-renewal or differentiation, as well as differentiated function in other cell types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305334     DOI: 10.1089/scd.2005.14.487

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  6 in total

Review 1.  Genetic modification of human embryonic stem cells.

Authors:  Xiaofeng Xia; Su-Chun Zhang
Journal:  Biotechnol Genet Eng Rev       Date:  2007

2.  Integrated microfluidic bioprocessor for single-cell gene expression analysis.

Authors:  Nicholas M Toriello; Erik S Douglas; Numrin Thaitrong; Sonny C Hsiao; Matthew B Francis; Carolyn R Bertozzi; Richard A Mathies
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

3.  The application of RNAi-based treatments for inflammatory bowel disease.

Authors:  Morten Tobias Jarlstad Olesen; Borja Ballarín-González; Kenneth Alan Howard
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

4.  Enhanced transfection efficiency of human embryonic stem cells by the incorporation of DNA liposomes in extracellular matrix.

Authors:  Luis G Villa-Diaz; Jose L Garcia-Perez; Paul H Krebsbach
Journal:  Stem Cells Dev       Date:  2010-09-29       Impact factor: 3.272

5.  Lipofectamine RNAiMAX: an efficient siRNA transfection reagent in human embryonic stem cells.

Authors:  Ming Zhao; Hong Yang; Xingjun Jiang; Wen Zhou; Bin Zhu; Ying Zeng; Kaitai Yao; Caiping Ren
Journal:  Mol Biotechnol       Date:  2008-03-08       Impact factor: 2.695

6.  A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells.

Authors:  Livia Eiselleova; Kamil Matulka; Vitezslav Kriz; Michaela Kunova; Zuzana Schmidtova; Jakub Neradil; Boris Tichy; Dana Dvorakova; Sarka Pospisilova; Ales Hampl; Petr Dvorak
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.